That argument doesn't mean spit to the New York regulators, who are concerned about the reliability of the online tests and their potential to send people rushing to their doctor demanding a cure for a fatal disease they may never get.
The current test the government uses in India, in which patients' spit is examined under a microscope, detects the disease in only about half of the cases but is used widely because it is cheap and relatively easy to perform.